UNITED THERAPEUTIC UTHR (NASDAQ)

(NEW YORK)A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus...READ MORE

(NEW YORK)Standard & Poor's Inc. included 10 U.S. health care companies among 73 companies based in the U.S. that made its annual Global Challengers, a list released Wednesday of midsized co...READ MORE

(NEW YORK)Large-cap biotech stocks are better positioned to bring investors returns during the second half of 2008 due to revenue gains and development deals, J.P. Morgan analysts said Tuesd...READ MORE

(WASHINGTON)The chairman and chief executive of United Therapeutics Corp. exercised options for 7,200 shares of common stock under a prearranged trading plan, according to a Securities and Exc...READ MORE

(WASHINGTON)The chairman and chief executive of United Therapeutics Corp. exercised options for 12,200 shares of common stock under a prearranged trading plan, according to a Securities and Ex...READ MORE

(WASHINGTON)The chairman and chief executive of United Therapeutics Corp. exercised options for 12,200 shares of common stock under a prearranged trading plan, according to a Securities and Ex...READ MORE

(NEW YORK)Shares of United Therapeutics Corp. rose Thursday after data showed that an inhaled version of its drug candidate to treat pulmonary arterial hypertension met its goal in a late-st...READ MORE